Medical network - July 13, dean diagnosis 12 evening announcement, announcement, the company second deliberated and adopted at the eighty-ninth meeting of the board of directors of the about foreign investment company set up in zhejiang big health industry equity funds (limited partnership) and bill of related party transactions. Dean diagnosis self-raised funds of 150 million yuan to be used and connects healthcare, business software and hangzhou Hao jointly established zhejiang win big health industry equity funds (limited partnership) (hereinafter referred to as the "fund").
Dean diagnosis was established in 2001, the chairman hai-bin Chen, 2011, dean diagnosis listed on the shenzhen stock exchange, and become the first independent third party medical laboratory in China. Companies to provide biochemical inspection, enzyme-linked immune, ria, PCR, such as thousands of kinds of medical testing services, business involves the diagnostic services, product sales, technology research and development production, cold chain logistics, and other fields.
On November 16, 2016, dean diagnosis was proposed with self-raised funds not more than 105 million yuan and the win assets, ZhuoYuan investment jointly established ningbo meishan bonded port area ZhuoRui equity funds of the partnership enterprise, the industry invest their way through equity investments and other special in medical health related investment, operation and management.
According to the announcement, the fund investment priorities in health field, focusing on medical services, precision medical health care and wisdom, etc. Foreign investment will take new equity, including but not limited to subscribe to the transferee in the form of equity and original.
Announcement, according to the funds in the form of limited partnership, survival period for 5 years, the total size less than 1.05 billion yuan. Among them, dean diagnosis, topchoice group health, business software as LP respectively offered 150 million yuan, 100 million yuan, 150 million yuan; Hangzhou Hao win as a GP and executing a transaction partner offered 10 million yuan, the rest amount fund raised abroad.
Fund distribution, according to the actually paid capital contribution ratio of each limited partner first to a limited partner of the principal of the allocation of investment, investment principal, assigned to a general partner again until all of the principal of the investment allocation. If there are any losses, partners according to the actually paid capital contribution ratio is collective burden.
In addition, the large investment set up zhejiang health industry equity funds (limited partnership) is the dean diagnosis based on long-term development of strategic exploration, the introduction of strategic investors, have experienced, and the strength of professional experience in investment management and make full use of the partner sound risk control system, in order to improve the level of investment decision, dispersed investment risks, to have good growth and development prospect of project investment, to enhance the profitability of the company.
Public data show that in 2016, dean diagnosis implement operating income of 3.824 billion yuan, up 105.79% from a year earlier; Net profit of 338 million yuan, up 89.03% from a year earlier.
|
